The Johns Hopkins Breast Human Specimen Resource and Database Core is an interdepartmental collaborative effort designed to support multi- disciplinary basic and translational research on the etiology, early detection, prevention and treatment of breast cancer and its precursor. The Core was designed using strategies that have proved successful in establishing tissue banks within the Department of Pathology and Core facilities for SPORE grants in gastrointestinal, prostate and pulmonary carcinoma at our institution. The Core provides flexible specimen collection techniques with quality assurance measures, inventory and tracking, collection of breast cancer risk factor information using questionnaire based on validated instruments and a secure relational database for storing and retrieving data with back-up files. Storage of frozen specimens, laboratory processing and data management will be performed in dedicated facilitated located in the newly constructed John Hopkins Cancer Center in immediate proximity to the operating rooms, surgical pathology laboratory, and research laboratories. The Core is designed to collect frozen breast tissue and cells, blood components, nipple fluid aspirates and other biological specimens. The Core is directed by an experienced pathologist with expertise in breast and gynecologic pathology and molecular epidemiology and will be staffed by trained technical personnel who report to the Director. The Co-PI of the Core is an experienced surgical pathologist and molecular biologist who has a special interest in breast cancer. The Core is a prospective collection of data and specimens donated by patients who either present to Johns Hopkins for initial diagnostic evaluation or have been referred to Hopkins following a diagnosis at another institution. Patients are recruited through two possible mechanisms intended to maximize subject participation. In addition to the prospectively acquired collection described below, the Breast Center has assess to retrospective collections of frozen and fixed breast specimens acquired at our institution and also has potential access to additional prospectively collected resources through collaborative agreements.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA088843-02
Application #
6500094
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-09-30
Project End
2002-09-29
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Lo, Pang-Kuo (2018) FOXF2 differentially regulates expression of metabolic genes in non-cancerous and cancerous breast epithelial cells. Trends Diabetes Metab 1:
Cravero, Karen; Medford, Arielle; Pallavajjala, Aparna et al. (2018) Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity. Pract Lab Med 12:e00108
Connolly, Roisin M; Fackler, Mary Jo; Zhang, Zhe et al. (2018) Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. Breast Cancer Res Treat 167:107-116
Connolly, Roisin M; Li, Huili; Jankowitz, Rachel C et al. (2017) Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study. Clin Cancer Res 23:2691-2701
Lo, Pang-Kuo (2017) The controversial role of forkhead box F2 (FOXF2) transcription factor in breast cancer. PRAS Open 1:
Haffner, Michael C; Esopi, David M; Chaux, Alcides et al. (2017) AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination. Nat Commun 8:142
Sunay, Melek M E; Foote, Jeremy B; Leatherman, James M et al. (2017) Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo. Int Immunopharmacol 46:112-123
Parsons, Heather A; Beaver, Julia A; Cimino-Mathews, Ashley et al. (2017) Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer. Clin Cancer Res 23:379-386
Sadik, Helen; Korangath, Preethi; Nguyen, Nguyen K et al. (2016) HOXC10 Expression Supports the Development of Chemotherapy Resistance by Fine Tuning DNA Repair in Breast Cancer Cells. Cancer Res 76:4443-56
Cidado, Justin; Wong, Hong Yuen; Rosen, D Marc et al. (2016) Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget 7:6281-93

Showing the most recent 10 out of 282 publications